On November 10 at the American Society of Nephrology 44th Annual Meeting, Boston University Assistant Professor of Medicine Laurence H. Beck, Jr., M.D., Ph.D. will present results from a study which found that H.P. Acthar® Gel may induce a remission of proteinuria in patients with idiopathic membranous nephropathy (iMN) by suppressing production of antibodies to the phospholipase A2 receptor (PLA2R). iMN is a common cause of nephrotic syndrome in adults. Nephrotic syndrome is a known risk factor for progression to end-stage renal disease (ESRD)...
More...
More...